Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN‐alpha in a patient with newly diagnosed ALL
Identifieur interne : 000103 ( Istex/Curation ); précédent : 000102; suivant : 000104Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN‐alpha in a patient with newly diagnosed ALL
Auteurs : Karin Mayer [Allemagne] ; Cordula Nellessen [Allemagne] ; Corinna Hahn-Ast [Allemagne] ; Martin Schumacher [Allemagne] ; Sandra Pietzonka [Allemagne] ; Anna M. Eis-Hübinger [Allemagne] ; Christian Drosten [Allemagne] ; Peter Brossart [Allemagne] ; Dominik Wolf [Allemagne]Source :
- European Journal of Haematology [ 0902-4441 ] ; 2016-08.
Abstract
Introduction: Human coronavirus NL63 (HCoV‐NL63) is one of four common human respiratory coronaviruses. Despite high incidence, HCoV infections are grossly understudied. We here report a case of HCoV infection in a leukemia patient with fatal ARDS despite successful virus elimination by pegylated interferon‐alpha (PEG‐IFN‐α). Case: The 27‐year‐old female pre‐T‐ALL patient was treated according to the German‐Multicenter Trial for Adult ALL protocol. No relevant infectious complications were seen until day 35 when the neutropenic patient developed fever without any clinical focus. Antibiotic prophylaxis was switched to meropenem. The patient deteriorated rapidly with respiratory failure due to ARDS. Anti‐infectious therapy was escalated to additional linezolid and liposomal amphotericine‐B. BAL revealed a significant viral load of HCoV‐NL63. Based on successful application of PEG‐IFN against the related SARS coronavirus in animal experiments, a single injection of 180 μg PEG‐IFN‐α2b was applied. Despite immediate initiation of treatment and elimination of virus in subsequent tests, the progressive lung failure led to death 7 d after onset of fever with massive lung bleeding as a consequence of diffuse alveolar hemorrhage. Conclusion: This report emphasizes the fatal consequences of common respiratory virus infections in immunocompromised patients. HCoV‐NL63 replication can be reduced by treatment with peg‐IFN if diagnosed early.
Url:
DOI: 10.1111/ejh.12744
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000103
Links to Exploration step
ISTEX:30742EB14E8B034C735517A8352C67D85EC42BACLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN‐alpha in a patient with newly diagnosed ALL</title>
<author><name sortKey="Mayer, Karin" sort="Mayer, Karin" uniqKey="Mayer K" first="Karin" last="Mayer">Karin Mayer</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: dominik.wolf@ukb.uni-bonn.de</mods:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Nellessen, Cordula" sort="Nellessen, Cordula" uniqKey="Nellessen C" first="Cordula" last="Nellessen">Cordula Nellessen</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hahn St, Corinna" sort="Hahn St, Corinna" uniqKey="Hahn St C" first="Corinna" last="Hahn-Ast">Corinna Hahn-Ast</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Schumacher, Martin" sort="Schumacher, Martin" uniqKey="Schumacher M" first="Martin" last="Schumacher">Martin Schumacher</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pietzonka, Sandra" sort="Pietzonka, Sandra" uniqKey="Pietzonka S" first="Sandra" last="Pietzonka">Sandra Pietzonka</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Virology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Eis Binger, Anna M" sort="Eis Binger, Anna M" uniqKey="Eis Binger A" first="Anna M." last="Eis-Hübinger">Anna M. Eis-Hübinger</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Virology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Virology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Brossart, Peter" sort="Brossart, Peter" uniqKey="Brossart P" first="Peter" last="Brossart">Peter Brossart</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wolf, Dominik" sort="Wolf, Dominik" uniqKey="Wolf D" first="Dominik" last="Wolf">Dominik Wolf</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: dominik.wolf@ukb.uni-bonn.de</mods:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:30742EB14E8B034C735517A8352C67D85EC42BAC</idno>
<date when="2016" year="2016">2016</date>
<idno type="doi">10.1111/ejh.12744</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-Z872XDS3-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000103</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000103</idno>
<idno type="wicri:Area/Istex/Curation">000103</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN‐alpha in a patient with newly diagnosed ALL</title>
<author><name sortKey="Mayer, Karin" sort="Mayer, Karin" uniqKey="Mayer K" first="Karin" last="Mayer">Karin Mayer</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: dominik.wolf@ukb.uni-bonn.de</mods:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Nellessen, Cordula" sort="Nellessen, Cordula" uniqKey="Nellessen C" first="Cordula" last="Nellessen">Cordula Nellessen</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hahn St, Corinna" sort="Hahn St, Corinna" uniqKey="Hahn St C" first="Corinna" last="Hahn-Ast">Corinna Hahn-Ast</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Schumacher, Martin" sort="Schumacher, Martin" uniqKey="Schumacher M" first="Martin" last="Schumacher">Martin Schumacher</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pietzonka, Sandra" sort="Pietzonka, Sandra" uniqKey="Pietzonka S" first="Sandra" last="Pietzonka">Sandra Pietzonka</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Virology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Eis Binger, Anna M" sort="Eis Binger, Anna M" uniqKey="Eis Binger A" first="Anna M." last="Eis-Hübinger">Anna M. Eis-Hübinger</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Virology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Virology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Brossart, Peter" sort="Brossart, Peter" uniqKey="Brossart P" first="Peter" last="Brossart">Peter Brossart</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wolf, Dominik" sort="Wolf, Dominik" uniqKey="Wolf D" first="Dominik" last="Wolf">Dominik Wolf</name>
<affiliation wicri:level="1"><mods:affiliation>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn (UKB), Bonn</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: dominik.wolf@ukb.uni-bonn.de</mods:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">European Journal of Haematology</title>
<title level="j" type="alt">EUROPEAN JOURNAL OF HAEMATOLOGY</title>
<idno type="ISSN">0902-4441</idno>
<idno type="eISSN">1600-0609</idno>
<imprint><biblScope unit="vol">97</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="208">208</biblScope>
<biblScope unit="page" to="210">210</biblScope>
<biblScope unit="page-count">3</biblScope>
<date type="published" when="2016-08">2016-08</date>
</imprint>
<idno type="ISSN">0902-4441</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0902-4441</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Introduction: Human coronavirus NL63 (HCoV‐NL63) is one of four common human respiratory coronaviruses. Despite high incidence, HCoV infections are grossly understudied. We here report a case of HCoV infection in a leukemia patient with fatal ARDS despite successful virus elimination by pegylated interferon‐alpha (PEG‐IFN‐α). Case: The 27‐year‐old female pre‐T‐ALL patient was treated according to the German‐Multicenter Trial for Adult ALL protocol. No relevant infectious complications were seen until day 35 when the neutropenic patient developed fever without any clinical focus. Antibiotic prophylaxis was switched to meropenem. The patient deteriorated rapidly with respiratory failure due to ARDS. Anti‐infectious therapy was escalated to additional linezolid and liposomal amphotericine‐B. BAL revealed a significant viral load of HCoV‐NL63. Based on successful application of PEG‐IFN against the related SARS coronavirus in animal experiments, a single injection of 180 μg PEG‐IFN‐α2b was applied. Despite immediate initiation of treatment and elimination of virus in subsequent tests, the progressive lung failure led to death 7 d after onset of fever with massive lung bleeding as a consequence of diffuse alveolar hemorrhage. Conclusion: This report emphasizes the fatal consequences of common respiratory virus infections in immunocompromised patients. HCoV‐NL63 replication can be reduced by treatment with peg‐IFN if diagnosed early.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000103 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000103 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:30742EB14E8B034C735517A8352C67D85EC42BAC |texte= Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN‐alpha in a patient with newly diagnosed ALL }}
This area was generated with Dilib version V0.6.33. |